glp-1 medications lean muscle retention weight loss From Fat Burn to Build: The Future of Obesity beyond GLP- 1 What Happens After GLP-1 Weight

Certain detrimental effects on a childs health are strongly correlated with maternal obesity and gestational diabetes underscoring the need for a safer and more efficient drug (89)

GLP-1-RA such as liraglutide [4], semaglutide [5], and the dual agonist tirzepatide [6], activating both the GLP1- and the gastric-inhibitory polypeptide receptor (GIP-R), have been shown to significantly reduce body weight, making them a promising therapeutic option for the treatment of obesity

Oral formulations appeal to needle-averse patients but require specific administration protocols for optimal absorption

Ensures safe and effective use of the medication

Average pulse rate increased by 3.7 bpm and 4.7 bpm with orforglipron 12 mg and 36 mg doses respectively